Updated October 28 at 12:28pm
74 results total, viewing 11 - 20
EpiVax Inc., the Rhode Island-based vaccine designer and maker of protein therapeutics, has formed a joint venture with Schroedinger LLC, a leading computational chemistry provider, to design “biosuperior” therapies to treat a range of diseases. more
EpiVax and French pharmaceutical company Ipsen recently announced a collaborative project to combat neurotoxins with novel biologic therapeutics. more
Ximedica, a medical-technology-development company, has acquired Accel Biotech based in Los Gatos, Calif. more
Rhode Island had three deals totaling $500,000 for venture capital-backed companies in the third quarter, according to CB Insights and KPMG International’s latest “Venture Pulse” report released Thursday. more
A national consultant has advised the I-195 Redevelopment District Commission to create a business innovation district in Providence that is larger than the existing footprint of undeveloped land, and to create an advisory council that would include the perspectives of anchor industries and universities. more
IlluminOss Medical Inc. said Monday that it has completed enrollment in its first U.S. clinical trial toward U.S. Food and Drug Administration approval of its IlluminOss System, a minimally invasive system to repair bone fractures. more
Dr. Barrett Bready is founder and CEO of Nabsys, a genomics firm. An adjunct professor at Brown University where he teaches biotechnology management, Bready also serves as a commissioner on the I-195 Redevelopment District Commission. Bready talked with Providence Business News about Nabsys’ evolution and goals for the future. more
Tech Collective is looking for volunteers for GRRL Tech 2016 to assist with workshops and chaperone. Those who work in STEM – science, technology, engineering and math – fields are welcome to apply. more
Richard A. Andrews recently was appointed chief operating officer at ProThera Biologics in Providence, a company that is developing inter-alpha inhibitor proteins to treat severe inflammation associated with infection, trauma and disease. He discussed his new role at the company with Providence Business News, as well as his past experience. more
Two hundred and fifteen college graduates working in science, technology, engineering and mathematics fields were chosen as the recipients of R.I. Commerce Corp.’s first Wavemaker Fellowships, a tax credit to defray student loan repayment. more
« Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 8 | Next »